Figure 1 summarizes the presumed associations between RA, sSS, anti-Ro/SS-A antibodies, and the therapeutic effects of DMARDs and LPD discussed in this article. The gene discussed is RO60; the disease is disseminated peritoneal leiomyomatosis.